Identification of High-Incidence Populations in the United States for Anti–Epstein-Barr Virus Serologic Screening for Nasopharyngeal Carcinoma
These data may aid the design of US screening trials. Targeted NPC screening might mitigate health disparities.
Authors
- Kekoa Taparra (ORCID: https://orcid.org/0000-0001-8493-3868)
- Jacob A. Miller (ORCID: https://orcid.org/0000-0002-8480-5492)
- Payton E. Clark
Institutions
- Cleveland Clinic (US)
- Palo Alto University (US)
- Cleveland Clinic Lerner College of Medicine (US)
Publication Details
- Journal
- Cancer Epidemiology Biomarkers & Prevention
- Published
- 2024-10-03
- DOI
- https://doi.org/10.1158/1055-9965.epi-24-0576
- Citations
- 5
- Primary Topic
- Viral-associated cancers and disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.41